Tempus Pro Monitor Registry

Completed

Conditions studied: Sudden Cardiac Arrest, Emergency Care

In brief

A multicenter, prospective and retrospective, observational, post market study.

Key facts

Study ID

NCT05587764

Run by

Philips Clinical & Medical Affairs Global

People needed

103

Starts

2024-04-25

Expected to finish

2024-08-12

Last updated by the study team

2025-03-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients monitored by using Tempus Pro during pre-hospital care (ambulance transportation)
• One or more 12-lead ECG recorded
• Use of 3 or more of the following sensors to measure vital signs
• NIBP (Non-Invasive Blood Pressure)
• HR (Heart Rate)
• SpO2 (Oxygen Saturation)
• PVI (Pleth Variability Index)
• SpCO (Carboxyhemoglobin)
• SpOC (Oxygen Content)
• SpHb (Total Hemoglobin)
• SpMet (Methemoglobin Saturation)
• EtCO2 (End-tidal Carbon Dioxide)

You may not qualify if…

• None defined

Where it is running

• Philips — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.